Systems and methods for the treatment of cancer using ultrasound
US-2025205467-A1 · Jun 26, 2025 · US
This page is not indexed by search engines while we improve data quality.
Osada Takuya patents
Osada Takuya is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Osada Takuya |
| Total patents | 28 |
| First publication | Jan 19, 2017 |
| Latest publication | Jun 26, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same
US-12083172-B2 · Sep 10, 2024 · US
X-ray psoralen activated cancer therapy (X-PACT)
US-11992697-B2 · May 28, 2024 · US
X-ray psoralen activated cancer therapy (x-pact)
US-2022226666-A1 · Jul 21, 2022 · US
X-ray psoralen activated cancer therapy (X-PACT)
US-11305131-B2 · Apr 19, 2022 · US
Cancer vaccines and methods of delivery
US-11253580-B2 · Feb 22, 2022 · US
Vaccines against antigens involved in therapy resistance and methods of using same
US-11235043-B2 · Feb 1, 2022 · US
X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
US-11207409-B2 · Dec 28, 2021 · US
Vaccines against antigens involved in therapy resistance and methods of using same
US-2021330773-A1 · Oct 28, 2021 · US
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
US-2021077606-A1 · Mar 18, 2021 · US
Recent patents
Latest publications not already listed above.
Vaccines against an oncogenic isoform of esr1 and methods of using the same
US-2021069309-A1 · Mar 11, 2021 · US
Vaccines against an oncogenic isoform of ESR1 and methods of using the same
US-10842855-B2 · Nov 24, 2020 · US
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same
US-10842857-B2 · Nov 24, 2020 · US
X-ray psoralen activated cancer therapy (x-pact)
US-2020009398-A1 · Jan 9, 2020 · US
Vaccines against HER3 antigens and methods of using the same
US-10487143-B2 · Nov 26, 2019 · US
X-ray psoralen activated cancer therapy (X-PACT)
US-10441810-B2 · Oct 15, 2019 · US
Cancer vaccines and methods of delivery
US-2019022204-A1 · Jan 24, 2019 · US
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
US-2018344824-A1 · Dec 6, 2018 · US
X-ray psoralen activated cancer therapy (x-pact) with associated treatments
US-2018344850-A1 · Dec 6, 2018 · US
Vaccines against an oncogenic isoform of esr1 and methods of using the same
US-2018326030-A1 · Nov 15, 2018 · US
Vaccines against antigens involved in therapy resistance and methods of using same
US-2018311329-A1 · Nov 1, 2018 · US
Her3 vaccine vector compositions and methods of using the same
US-2018282736-A1 · Oct 4, 2018 · US
Vaccines against antigens involved in therapy resistance and methods of using same
US-9956276-B2 · May 1, 2018 · US
Vaccines against her3 antigens and methods of using the same
US-2018094050-A1 · Apr 5, 2018 · US
Vaccines against an oncogenic isoform of esr1 and methods of using the same
US-2017196952-A1 · Jul 13, 2017 · US
VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
US-2017196953-A1 · Jul 13, 2017 · US
X-ray psoralen activated cancer therapy (x-pact)
US-2017157418-A1 · Jun 8, 2017 · US
Compositions And Methods For Modulating And Redirecting Immune Responses
US-2017015758-A1 · Jan 19, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Duke | 28 |
| Immunolight Llc | 8 |
| Univ North Carolina State | 1 |
| Medimmune Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 25 |
| A61K39/001106 | 17 |
| A61K2039/53 | 17 |
| C07K2317/76 | 15 |
| A61K39/0011 | 15 |